Home Biosimilar Antibodies Others Others null Dinutuximab (Anti-GD2) For research use only.
Not for use in humans.

Dinutuximab (Anti-GD2)

Dinutuximab (Anti-GD2) is a chimeric mouse/human monoclonal antibody that targets ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. It has potential antineoplastic activity. MW: 145.5 KD.

Dinutuximab (Anti-GD2)

Purity & Quality Control

Batch: A248501 Purity: 99% Protein concentration: 11.26mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Dinutuximab (Anti-GD2) is a chimeric mouse/human monoclonal antibody that targets ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. It has potential antineoplastic activity. MW: 145.5 KD.

Product Details

CAS No. 1363687-32-4 
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) supplier | purchase Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) cost | Dinutuximab (Anti-GD2) manufacturer | order Dinutuximab (Anti-GD2) | Dinutuximab (Anti-GD2) distributor